| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0016604 | nuclear body | 2 | 2 |
| GO:0031422 | RecQ family helicase-topoisomerase III complex | 3 | 2 |
| GO:0031974 | membrane-enclosed lumen | 2 | 2 |
| GO:0031981 | nuclear lumen | 5 | 2 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
| GO:0032991 | protein-containing complex | 1 | 2 |
| GO:0043233 | organelle lumen | 3 | 2 |
| GO:0070013 | intracellular organelle lumen | 4 | 2 |
| GO:0097014 | ciliary plasm | 5 | 2 |
| GO:0099568 | cytoplasmic region | 3 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:1902494 | catalytic complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q9R3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000712 | resolution of meiotic recombination intermediates | 4 | 2 |
| GO:0000724 | double-strand break repair via homologous recombination | 7 | 2 |
| GO:0000725 | recombinational repair | 6 | 2 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
| GO:0006259 | DNA metabolic process | 4 | 2 |
| GO:0006281 | DNA repair | 5 | 2 |
| GO:0006302 | double-strand break repair | 6 | 2 |
| GO:0006310 | DNA recombination | 5 | 2 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0006950 | response to stress | 2 | 2 |
| GO:0006974 | DNA damage response | 4 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0022402 | cell cycle process | 2 | 2 |
| GO:0022414 | reproductive process | 1 | 2 |
| GO:0033554 | cellular response to stress | 3 | 2 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
| GO:0046483 | heterocycle metabolic process | 3 | 2 |
| GO:0050896 | response to stimulus | 1 | 2 |
| GO:0051716 | cellular response to stimulus | 2 | 2 |
| GO:0061982 | meiosis I cell cycle process | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0090304 | nucleic acid metabolic process | 4 | 2 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
| GO:1903046 | meiotic cell cycle process | 2 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 2 |
| GO:0004518 | nuclease activity | 4 | 2 |
| GO:0004519 | endonuclease activity | 5 | 2 |
| GO:0016787 | hydrolase activity | 2 | 2 |
| GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 132 | 136 | PF00656 | 0.510 |
| CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.517 |
| CLV_C14_Caspase3-7 | 278 | 282 | PF00656 | 0.795 |
| CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.707 |
| CLV_NRD_NRD_1 | 485 | 487 | PF00675 | 0.523 |
| CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.707 |
| CLV_PCSK_KEX2_1 | 485 | 487 | PF00082 | 0.524 |
| CLV_PCSK_SKI1_1 | 382 | 386 | PF00082 | 0.639 |
| DEG_ODPH_VHL_1 | 37 | 49 | PF01847 | 0.643 |
| DEG_SCF_FBW7_1 | 68 | 75 | PF00400 | 0.530 |
| DOC_ANK_TNKS_1 | 484 | 491 | PF00023 | 0.521 |
| DOC_CKS1_1 | 40 | 45 | PF01111 | 0.577 |
| DOC_CYCLIN_RxL_1 | 160 | 171 | PF00134 | 0.482 |
| DOC_CYCLIN_RxL_1 | 445 | 456 | PF00134 | 0.497 |
| DOC_MAPK_gen_1 | 96 | 104 | PF00069 | 0.566 |
| DOC_PP2B_LxvP_1 | 208 | 211 | PF13499 | 0.449 |
| DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.607 |
| DOC_USP7_MATH_1 | 283 | 287 | PF00917 | 0.788 |
| DOC_USP7_MATH_1 | 296 | 300 | PF00917 | 0.759 |
| DOC_USP7_MATH_1 | 72 | 76 | PF00917 | 0.664 |
| DOC_WW_Pin1_4 | 114 | 119 | PF00397 | 0.535 |
| DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.742 |
| DOC_WW_Pin1_4 | 361 | 366 | PF00397 | 0.619 |
| DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.612 |
| DOC_WW_Pin1_4 | 392 | 397 | PF00397 | 0.448 |
| DOC_WW_Pin1_4 | 407 | 412 | PF00397 | 0.595 |
| DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.733 |
| LIG_14-3-3_CanoR_1 | 111 | 118 | PF00244 | 0.576 |
| LIG_14-3-3_CanoR_1 | 207 | 211 | PF00244 | 0.526 |
| LIG_14-3-3_CanoR_1 | 448 | 453 | PF00244 | 0.461 |
| LIG_14-3-3_CanoR_1 | 480 | 484 | PF00244 | 0.516 |
| LIG_APCC_ABBA_1 | 245 | 250 | PF00400 | 0.537 |
| LIG_APCC_ABBAyCdc20_2 | 63 | 69 | PF00400 | 0.707 |
| LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.562 |
| LIG_FHA_1 | 207 | 213 | PF00498 | 0.532 |
| LIG_FHA_1 | 350 | 356 | PF00498 | 0.485 |
| LIG_FHA_1 | 384 | 390 | PF00498 | 0.530 |
| LIG_FHA_1 | 42 | 48 | PF00498 | 0.668 |
| LIG_FHA_1 | 426 | 432 | PF00498 | 0.522 |
| LIG_FHA_1 | 461 | 467 | PF00498 | 0.563 |
| LIG_FHA_1 | 77 | 83 | PF00498 | 0.572 |
| LIG_LIR_Gen_1 | 170 | 179 | PF02991 | 0.476 |
| LIG_LIR_Gen_1 | 342 | 351 | PF02991 | 0.367 |
| LIG_LIR_Gen_1 | 386 | 393 | PF02991 | 0.448 |
| LIG_LIR_LC3C_4 | 299 | 304 | PF02991 | 0.675 |
| LIG_LIR_Nem_3 | 170 | 176 | PF02991 | 0.471 |
| LIG_LIR_Nem_3 | 342 | 348 | PF02991 | 0.334 |
| LIG_LIR_Nem_3 | 386 | 390 | PF02991 | 0.456 |
| LIG_LIR_Nem_3 | 445 | 450 | PF02991 | 0.418 |
| LIG_MYND_1 | 35 | 39 | PF01753 | 0.623 |
| LIG_SH2_CRK | 387 | 391 | PF00017 | 0.521 |
| LIG_SH2_STAP1 | 387 | 391 | PF00017 | 0.521 |
| LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.631 |
| LIG_SH3_2 | 325 | 330 | PF14604 | 0.566 |
| LIG_SH3_3 | 151 | 157 | PF00018 | 0.562 |
| LIG_SH3_3 | 25 | 31 | PF00018 | 0.653 |
| LIG_SH3_3 | 301 | 307 | PF00018 | 0.705 |
| LIG_SH3_3 | 308 | 314 | PF00018 | 0.715 |
| LIG_SH3_3 | 322 | 328 | PF00018 | 0.599 |
| LIG_SH3_3 | 338 | 344 | PF00018 | 0.501 |
| LIG_SH3_3 | 437 | 443 | PF00018 | 0.535 |
| LIG_SUMO_SIM_anti_2 | 458 | 463 | PF11976 | 0.519 |
| LIG_SUMO_SIM_anti_2 | 79 | 84 | PF11976 | 0.475 |
| LIG_SUMO_SIM_par_1 | 175 | 181 | PF11976 | 0.538 |
| LIG_TRAF2_1 | 140 | 143 | PF00917 | 0.541 |
| MOD_CK1_1 | 106 | 112 | PF00069 | 0.556 |
| MOD_CK1_1 | 114 | 120 | PF00069 | 0.537 |
| MOD_CK1_1 | 183 | 189 | PF00069 | 0.552 |
| MOD_CK1_1 | 306 | 312 | PF00069 | 0.779 |
| MOD_CK1_1 | 55 | 61 | PF00069 | 0.753 |
| MOD_CK2_1 | 450 | 456 | PF00069 | 0.577 |
| MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.381 |
| MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.351 |
| MOD_GlcNHglycan | 180 | 185 | PF01048 | 0.362 |
| MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.803 |
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.717 |
| MOD_GSK3_1 | 103 | 110 | PF00069 | 0.510 |
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.642 |
| MOD_GSK3_1 | 212 | 219 | PF00069 | 0.582 |
| MOD_GSK3_1 | 258 | 265 | PF00069 | 0.654 |
| MOD_GSK3_1 | 277 | 284 | PF00069 | 0.682 |
| MOD_GSK3_1 | 303 | 310 | PF00069 | 0.771 |
| MOD_GSK3_1 | 349 | 356 | PF00069 | 0.474 |
| MOD_GSK3_1 | 405 | 412 | PF00069 | 0.687 |
| MOD_GSK3_1 | 55 | 62 | PF00069 | 0.759 |
| MOD_GSK3_1 | 68 | 75 | PF00069 | 0.672 |
| MOD_NEK2_1 | 103 | 108 | PF00069 | 0.581 |
| MOD_NEK2_1 | 257 | 262 | PF00069 | 0.655 |
| MOD_NEK2_1 | 285 | 290 | PF00069 | 0.723 |
| MOD_NEK2_1 | 385 | 390 | PF00069 | 0.524 |
| MOD_NEK2_1 | 450 | 455 | PF00069 | 0.480 |
| MOD_PIKK_1 | 248 | 254 | PF00454 | 0.513 |
| MOD_PIKK_1 | 296 | 302 | PF00454 | 0.706 |
| MOD_PIKK_1 | 400 | 406 | PF00454 | 0.597 |
| MOD_PIKK_1 | 55 | 61 | PF00454 | 0.695 |
| MOD_PKA_2 | 110 | 116 | PF00069 | 0.576 |
| MOD_PKA_2 | 155 | 161 | PF00069 | 0.520 |
| MOD_PKA_2 | 206 | 212 | PF00069 | 0.517 |
| MOD_PKA_2 | 262 | 268 | PF00069 | 0.692 |
| MOD_PKA_2 | 33 | 39 | PF00069 | 0.607 |
| MOD_PKA_2 | 400 | 406 | PF00069 | 0.572 |
| MOD_PKA_2 | 479 | 485 | PF00069 | 0.495 |
| MOD_Plk_1 | 134 | 140 | PF00069 | 0.487 |
| MOD_Plk_1 | 213 | 219 | PF00069 | 0.525 |
| MOD_Plk_1 | 6 | 12 | PF00069 | 0.675 |
| MOD_Plk_1 | 90 | 96 | PF00069 | 0.487 |
| MOD_Plk_2-3 | 425 | 431 | PF00069 | 0.433 |
| MOD_Plk_2-3 | 6 | 12 | PF00069 | 0.643 |
| MOD_Plk_4 | 385 | 391 | PF00069 | 0.560 |
| MOD_Plk_4 | 78 | 84 | PF00069 | 0.363 |
| MOD_ProDKin_1 | 114 | 120 | PF00069 | 0.535 |
| MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.743 |
| MOD_ProDKin_1 | 361 | 367 | PF00069 | 0.628 |
| MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.614 |
| MOD_ProDKin_1 | 392 | 398 | PF00069 | 0.449 |
| MOD_ProDKin_1 | 407 | 413 | PF00069 | 0.599 |
| MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.729 |
| MOD_SUMO_rev_2 | 493 | 501 | PF00179 | 0.398 |
| TRG_DiLeu_BaLyEn_6 | 28 | 33 | PF01217 | 0.754 |
| TRG_ENDOCYTIC_2 | 387 | 390 | PF00928 | 0.525 |
| TRG_ER_diArg_1 | 26 | 28 | PF00400 | 0.518 |
| TRG_ER_diArg_1 | 484 | 486 | PF00400 | 0.431 |
| TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.581 |
| TRG_NES_CRM1_1 | 168 | 181 | PF08389 | 0.562 |
| TRG_NES_CRM1_1 | 236 | 250 | PF08389 | 0.562 |
| TRG_Pf-PMV_PEXEL_1 | 163 | 168 | PF00026 | 0.362 |
| TRG_Pf-PMV_PEXEL_1 | 175 | 180 | PF00026 | 0.362 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I876 | Leptomonas seymouri | 54% | 100% |
| A0A0S4ILE1 | Bodo saltans | 26% | 100% |
| A0A1X0NY87 | Trypanosomatidae | 30% | 100% |
| A0A3S7WZC3 | Leishmania donovani | 94% | 100% |
| A0A422NGJ8 | Trypanosoma rangeli | 30% | 100% |
| A4HEG6 | Leishmania braziliensis | 78% | 100% |
| A4I1M4 | Leishmania infantum | 94% | 100% |
| C9ZK66 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
| E9AXQ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| V5DIU3 | Trypanosoma cruzi | 34% | 100% |